FDA Authorizes New Covid-19 ‘Updated Booster’ Shots Without Trials on Humans

Moderna CEO Stephane Bancel at the World Economic Forum in Davos, Switzerland

@media (max-width: 1200px) { }.novashare-inline:not(.novashare-columns) .novashare-buttons-wrapper { justify-content: center; }body .novashare-inline:not(.novashare-columns) a.novashare-button, body .novashare-inline .novashare-total-share-count { margin: 0px 5px 10px 5px; }body .novashare-buttons.novashare-inline .novashare-button-icon { width: 100%; }

The Food and Drug Administration (FDA) has authorized the latest COVID-19 “updated booster” shots, developed for the Omicron variant, without running trials on humans, meaning those lining up for the jabs will be the trial subjects.

In lieu of human trials, the vaccines will rely on testing on mice and will be approved for public use months before human trials are complete. The new Omicron shots were approved by the FDA on Wednesday, reports Fox.

“Today, the U.S. Food and Drug Administration amended the emergency use authorizations (EUAs) of the Moderna COVID-19 Vaccine and the Pfizer-BioNTech COVID-19 Vaccine to authorize bivalent formulations of the vaccines for use as a single booster dose at least two months following primary or booster vaccination,” it said in a statement.

Latest Videos

[embedded content]

The new shots, which the FDA is referring to as “updated boosters,” contain “two messenger RNA (mRNA) components of SARS-CoV-2 virus, one of the original strain of SARS-CoV-2 and the other one in common between the BA.4 and BA.5 lineages of the omicron variant of SARS-CoV-2.”

Despite not having been tested on humans, the vaccination will be pushed by the government on all Americans.

Aside from testing on mice, the FDA will also rely on data from current COVID-19 vaccines, and earlier iterations of boosters.

In June, two health experts wrote an op-ed urging the FDA not to release the booster shots without proper research.

The article was written by John P. Moore – a virologist and professor of microbiology and immunology at Weill Cornell Medicine – and Paul A. Offit – a pediatrician, professor of pediatrics, director of the Vaccine Education Center at the Children’s Hospital of Philadelphia, and a member of the Vaccines and Related Biological Products Advisory Committee.

Offit told the Wall Street Journal, “I’m uncomfortable that we would move forward — that we would give millions or tens of millions of doses to people — based on mouse data.”

[embedded content]

Baxter Dmitry

Baxter Dmitry is a writer at News Punch. He covers politics, business and entertainment. Speaking truth to power since he learned to talk, Baxter has travelled in over 80 countries and won arguments in every single one. Live without fear.
Email: [email protected]

Latest posts by Baxter Dmitry (see all)

Source

Views: 0

You can skip to the end and leave a response. Pinging is currently not allowed.

Leave a Reply

Powered by WordPress | Designed by: Premium WordPress Themes | Thanks to Themes Gallery, Bromoney and Wordpress Themes